Since the constitutive activation of PI3K/AKT signaling cascade is frequently observed in human cancer phenotypes and crucially related with cancer cell proliferation, survival, invasion and angiogenesis, the inhibition of PI3K/AKT pathway has become an attractive approach for liver cancer treatment [52], [53]. The gene discussed is AKT1; the disease is cancer.